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Marijuana Legalization: Beyond Yes or No
Introduction
“Marijuana Legalization: Beyond Yes or No,” is unquestionably a hot 
political topic. However, this is not a political paper and I do not 
take a political position. What I will do instead is give you a policy 
research perspective and discuss the different levers we could pull, 
and what their impact might be. The most important lesson of 
cannabis policy research is that we have many options rather than 
facing a blanket yes or no decision. We have choices and needn’t 
confine ourselves to picking between a war on marijuana on the 
one hand, and a clone of the tobacco industry on the other. There 
are plenty of other cannabis policy options, whether it is legal or 
illegal, and those options should be left to you as voters. 
This paper will first go over some basic terms and concepts, then 
discuss what’s going on in the world around cannabis with a focus on 
the United States. I will then offer some policy options to consider if 
New York chooses to legalize recreational cannabis. There are four 
terms I’m going to discuss throughout this paper that are often used 
carelessly or incorrectly in the media, and sometimes in academia 
too. So let me begin by defining decriminalization, legalization, 
commercialization, and normalization. 
Decriminalization
Decriminalization is not the same thing as legalization. It is about 
the user, the person who smokes pot or consumes the marijuana-
filled brownie. Decriminalization is focused on removing criminal 
penalties for using cannabis and for possessing small quantities 
of the drug for personal use. There are different varieties of it. 
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Sometimes there is no arrest, but you still have to pay the equivalent 
of a parking ticket. Sometimes you have to do a court appearance, 
but as long as you do it, your record will be waived. However, the 
general idea is that you are taking away or greatly reducing criminal 
penalties and the long term costs that can accompany them. For 
example, having a criminal record can affect someone’s ability to 
get a job, secure housing, or get a student loan. Decriminalization 
would get rid of that.
What does decriminalization do to drug use? 
People often worry if marijuana is decriminalized, then everybody 
will start using a lot more of the drug. The evidence shows that 
usage may increase a little, but it is not a huge effect. Some increase 
in cannabis usage can happen because criminal punishment can be 
thought of as a cost, even though it’s inconsistently applied (i.e., 
You probably won’t have to “pay it”, but you can’t rule it out). 
Therefore, once people know there is no chance they will have 
to pay that cost, there will be at least some people who will say, 
“Okay, I’d like to try this now that I know I can’t get arrested.” So, 
that can increase population cannabis use, but the effect is small. In 
contrast, the effect of decriminalization on arrests is huge.
Figure 1
Marijuana Possession Arrests in California Collapsed 




The state of California decriminalized cannabis in 2010 both for 
adults and for young people. You can see the drop in arrests in 
Figure 1. The graph represents 12 months of data that embodies 
an 87% drop in arrests in the youth population, as well as in the 
adult population (Males, 2012). That’s almost every single cannabis 
possession arrest that police used to make in California. 
You can see the same thing in other countries as well. In Western 
Australia, police began issuing Cannabis Expiation Notices, rather 
than making arrests for cannabis use/possession. Authorities 
would write you up and say, “You’ve done this thing,” and they 
would take the cannabis and say, “But, you can avoid any criminal 
sanction.” Researchers evaluated how many of the people who had 
one contact with the police around cannabis, had contact with the 
police again, meaning something else bad had happened. It used 
to be one-third of people would be repeat business and it went to 
zero (Babor et al., 2018). That is truly taking cannabis users out of 
contact with the police. There are many social welfare gains from 
doing that. For example, the police can do other things that many 
people would argue are more important, and you do not have the 
arrest damage which can be substantially worse than the use of the 
pot. 
Some people worry about net-widening, which is a concept from 
criminology roughly stating that if you make the penalty really 
modest, then police will start applying it more. The idea is that 
before decriminalization, police officers would say, “Well, it’s just a 
joint. I don’t want to give the person a criminal record.” But when 
the penalty changes to being just a ticket, they say, “Well, if it’s 
just a ticket, I’ll do it.” This has happened in some locations after 
decriminalization, but it does not seem to be a big effect or the 
norm. So we are pretty safe in concluding that decriminalization 
wipes out almost every cannabis possession arrest and reduces 
police interaction with users. 
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To summarize, decriminalization certainly cuts arrests if they 
were prevalent to begin with. Clearly, if the police had long ago 
stopped making cannabis possession arrests (which happens 
in some locations), formally ratifying the de facto policy in a 
decriminalization law won’t reduce arrests because they aren’t 
happening anyway. But assuming police were making a lot of 
possession arrests, decriminalization will dramatically cut them 
back to nothing or nearly nothing. The policy thus presents a value 
judgement for voters: would they accept a bit more cannabis use 
and a lot fewer cannabis arrests. Whether that’s a good trade or 
not is a political question and not a scientific one. 
The reason cannabis usage does not change much under 
decriminalization is because of what Peter Reuter, a drug policy 
analyst, describes as structural consequences of illegality for the 
industry (Reuter, 1983). When growing, promoting, and selling 
cannabis is illegal, cannabis becomes less accessible and more 
expensive. Decriminalization maintains those constraints on 
cannabis producers and sellers. In other words, society can remove 
penalties on users without creating legal cannabis corporations. You 
do not have to have full legalization in order to eliminate criminal 
penalties for cannabis users. 
Why Decriminalization and Not Legalization is How Arrests are 
Reduced
Another thing to note is people often believe that cannabis 
legalization will reduce arrests. Oddly enough, it generally will not. 
If you had a state that had an extremely tough marijuana regime 
and they are arresting people like crazy, and they went straight 
to legalization, then they would see a big fall in their arrests. But 
the political reality is, those aren’t the states that make the move 
to legalization. Instead, states that legalize almost always have 
decriminalized first. By the time legalization starts to appear as 
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a viable policy, there just are not that many arrests left because 
decriminalization has already eliminated them. 
Will Decriminalization Reduce Imprisonment?
If you decriminalize, does it empty out the prisons? No. When 
political candidates say, “I have a plan to get rid of mass incarceration 
in this country. I’m going to release all the pot smokers from prison,” 
my reaction is, “Really, both of them? Thanks for taking a bold stand 
in life!” People do not go to prison for smoking pot. Even if you take 
the broadest definition of a marijuana offense and include people 
who had 500 pounds of marijuana, a gun, and were evading taxes 
when they were caught, it still only adds up to 1% or 2% of the 
American prison population (Caulkins et al., 2016). Maybe you still 
want to release those people. That is an interesting debate to have; 
however, fundamentally, you are leaving 98% to 99% of the prison 
population on the table. That being said, changing cannabis policy, 
contrary to what some have promised, is not going to alter the fact 
that we have nearly 1.5 million human beings in state and federal 
prison (Bronson & Carson, 2019).
Legalization
Legalization goes beyond decriminalization by saying not only that 
it’s okay to use and possess cannabis for personal use, but also 
that people can grow large amounts of it and also sell it. When 
cannabis production and supply become legal, it does something 
decriminalization does not: create competition for a black market. 
If you decriminalize, people are still buying from criminals. If you 
legalize, the black market should – at least in the long term - shrivel 
because legalization can provide a cheaper product that people 
can buy and sell without any risk of arrest. As a result, criminal 
sellers should go out of business, as did bootleggers when alcohol 
prohibition ended (Cook, 2007). The other effects of legalization 
depend enormously on how it’s designed, which is why it’s vital to 
through all the policy options available.




(Caulkins et al., 2015)
Figure 2 is adapted from the RAND Corporation team, which is 
led by Jonathan Caulkins and Beau Kilmer. The figure presents a 
range of alternatives for handling the supply part of cannabis policy 
(Caulkins et al., 2015). The options range from saying, “Well, we 
aren’t legalizing supply and production but we’re going to lower the 
penalties,” to the other end of the continuum which is, “We’re going 
to have another big tobacco; we’re going to have a whole private 
sector free-for-all.” However, there are many options in between. 
You could say, “We’ll let people grow their own, so everyone is a 
legal producer”, or “We’ll just let adults grow it”, or “We’ll have 
clubs that grow it like Spain does.” Or you could adopt the Dutch 
model which has cafes where you can legally sell, purchase, and use 
cannabis, but you cannot consume it other places. 
You could also have “state stores” as the only legal sellers. If you 
are old enough and you grew up in the right part of the country, 
you will remember that state governments used to run liquor 
stores after Prohibition. In those states, the state stores advertised 
less, they carded more consistently, and there was less drinking. 
You could employ that as a model for cannabis legalization. Yet 
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another possible model is to have public benefit companies which 
sell cannabis but are non-profit. Alternatively, if legalization allows 
private sales, the policy could license very strictly or versus loosely. 
In short, there is a huge range of options here. One of the things 
I think that has been bad about our polarized political debate is 
that mainly what we have been presented with is just the standard 
commercial model. In other words, voters are asked to pick between 
lots of people being arrested or having tobacco-style cannabis 
corporations, which is a false choice. We have a lot more flexibility 
than that. 
Commercialization
Commercialization is a process that legalization makes possible, 
but is distinct. Commercialization is when you bring in modern 
marketing, advertising, profit-seeking, and heavy promotion. 
There is good evidence that this has unique effects different from 
legalizing a business per se. I can show you that by talking about 
the Dutch. The Dutch do things very carefully. They gather data 
and then they pragmatically say, “Let’s switch this and switch that.” 
There is all this great data on cannabis from them, and they have 
been working on this for decades. The Dutch had an experiment 
to set up cannabis cafes. When they set up the cafes, some people 
said, “Everyone’s going to be high all the time.” However, very little 
evidence showed that setting up these designated spots where 
you could legally consume cannabis changed consumption that 
much (MacCoun, 2011). It turned out that it was not that big of a 
deal. However, over time that industry evolved and they opened 
up more cafes and started advertising, including in other countries, 
and having two-for-one sales, and all the things we associate with 
modern commerce. It was then that Dutch consumption tripled in 
a period where nowhere else in Europe changed. So, the Dutch, 
being Dutch, said, “Well, we don’t like that,” so they crimped down 
on the commercialization aspects, while still keeping the cafes, and 
showed that use went back down. Now the Dutch rate of cannabis 
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use is unremarkable; it looks like any other European country. 
This was documented by my colleague at Stanford, Rob MacCoun 
(MacCoun, 2011). I believe that is as close you can get to an 
experiment. Taking away the criminal sanctions for cannabis sales 
and production is one thing; unleashing the full force of capitalism 
on a drug is another. However, you do not have to do that in order 
to legalize, the Dutch have shown that there are alternative ways. 
Normalization
Normalization is a process that is not specified in policy but is 
shaped by policy. Just imagine if I walked into this room and my 
necktie was wrapped over my face instead of hanging down in the 
normal way. As I said, “It’s great to see you all. I’m really happy to 
be here in Syracuse,” you wonder, “God, how did we get such a 
weirdo for a speaker?,” even though it’s perfectly legal to wear a 
necktie over one’s face. I would look at your negative non-verbal 
reactions and put my tie back down because I do not want to be 
considered a weirdo.
This is a silly example, but it’s relevant because a huge amount 
of our conduct around substances has less to do with laws than 
it does what is considered normal in our social space. If this were 
1950, we would all be smoking cigarettes. Now, it is illegal, but even 
if it were not illegal, lighting up a cigarette in public, lots of places 
people will look at you like, “Ew, gross, cigarettes.” Or another one 
you may remember if you’re my age is how people feel about drunk 
driving. People in the 1950s made jokes about drunk driving: it was 
no big deal. Now, if you are wobbling out of a party drunk and say, 
“I’m going to have one more for the road,” everyone looks at you 
as if you are a pariah. Those things affect us a lot because we are 
far more in contact with other people than we are with the formal 
forces of law. So what happens if beyond becoming legal, cannabis 
becomes normalized? What happens if it becomes a banal thing, 
as common as someone saying, “I’d like a beer,” to have cannabis 
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openly displayed in my home or in my office? That would probably 
have effects of its own as well. Part of that will be on how people 
interpret what cannabis means in their lives and what a cannabis 
problem is.
Below is a story about a woman and her son. This comes from a 
combination of some people and it is all anonymized so no one’s 
privacy is violated. Imagine this situation:
“Sally is a 40-year-old accountant who is recently divorced. 
Her 16-year-old son Richard has seemed sad and low on 
energy since the marital breakup. Richard smokes marijuana 
every day, both before and after school. He has trouble 
sleeping and has also gained a large amount of weight. 
Both his friendships and his grades have deteriorated”
If you’re Sally, the parent, you want to know what’s wrong with 
your child. There is a lot going on in Richard’s life and it is somewhat 
arbitrary which problem is considered the “real” problem. In the 
perfect world of randomized clinical trials, people only have one 
problem and everyone with multiple problems is excluded from 
enrolling. However, in real life these things are all mixed up. 
Therefore, judgements about what is wrong with Richard is going to 
depend in part on what is normalized, who Sally talks to, and what 
they say. Let’s say it’s the late 1980s, the height of the American 
anti-marijuana era, and Sally talks to her neighbor. The neighbor 
might say, “I’m hearing marijuana is really bad. Richard has a 
marijuana problem. You need to get him into addiction treatment. 
That’s why he’s depressed, that’s why he’s gaining weight, and 
that’s why he doing badly in school.” However, if cannabis use were 
totally normalized, then the neighbor probably wouldn’t say that. 
They might say things like, “Well, you know, it’s tough to deal with 
divorce, that’s all,” or, “Kids go through these phases. It’s nothing,” 
or, “He’s got an eating disorder,” or, “Maybe he needs a tutor and 
needs to learn how to study better.” 
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Any of these analyses of Richard’s problem may be true or false. We 
do not know which his problem truly is. However, the point is just 
that. Whether we fully normalize and we come to think that using 
cannabis is banal, it will change how many people think about their 
problems and whether or not they seek help. Sometimes that will 
be good because the problem isn’t the cannabis, and sometimes 
that will be bad because the problem is the cannabis. The force of 
normalization is wrapped up in many other political and economic 
forces, for example it’s absolutely clear that corporate industries try 
to normalize use of their products. But they aren’t the only player 
– all of us have some power to shape the social norms around 
substance use in the circles in which we move.
Global Developments
So what’s going on out there on this wild planet of ours? Well, I 
have mentioned the Netherlands. They are still experimenting and 
trying different things. They have recently decided that you have to 
have a Dutch passport to get cannabis out of cafés near the border, 
like in the city of Maastricht. Spain has membership clubs that you 
can use cannabis in legally. Uruguay has legalized cannabis use and 
they sell it through a pharmacy system. Canada has legalized, with 
the provinces allowed to have a fair amount of latitude of how 
they want to design it, which I believe are going to range from free 
market to a state monopoly model. 
Then, there is the United States. The remainder of this paper will talk 
about us, because that is where we have the most data. American 
exceptionalism gets a bad name as a concept but sometimes, it is 
warranted. We do seem to be different from any other country in 
the amount of freedom we give corporations to do what it is they’d 
like to do. That likely means that our form of legalization will be 
different from what you would see in other countries. Therefore, 
we need to keep that in mind and not say we have to yield to that 
automatically, but just assume that potentially what we do is not 
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going to generalize to other countries and what other countries do 
may not generalize to what we do. 
Right now almost all the good outcome data that we have is from 
the U.S., with some exceptions. What is being done ranges from for 
profit free-for-alls to better regulated systems. Eleven states and the 
District of Columbia have legal recreational marijuana right now. 
Other states have medical marijuana that is so loosely regulated 
that it is almost de facto legalization of recreational marijuana. 
This was true in some of the legalization states (e.g., Washington & 
California) before they formally legalized. It was easy to get access 
for almost any reason and use as much as you wanted. Cannabis is 
still federally illegal which creates some very awkward situations 
in legalizing states. Everything that is going on now in the “legal” 
marijuana industry is a federal felony, but the federal government is 
not doing anything about it. This raises challenging questions about 
interstate commerce and banking and other areas overseen by the 
federal government. However, those state-federal contradictions 
are just the way it is, at least for the moment. 
Most legalization in the U.S. is on a private for-profit model. Vermont 
and Washington, D.C. are exceptions, although they are both under 
threat. There you can grow it, you can use it, you can possess it, you 
can give it away, but you can’t run a business by selling it. The longer-
term trends in the U.S. are decriminalization and normalization. 
If you look at how much people are smoking marijuana, you will 
see it has roughly doubled the volume of consumption in the last 
10 years or so. Yet the amount of arrests per use have gone down 
quite a bit. More generally, even outside the states you are seeing 
a move away from enforcement against this drug. 
Public Health Impact
What is going to be the public health impact of legalization? I’m 
going to discuss seven things: (1) What happens to prices and 
why they collapse. (2) What does that mean for taxes? (3) What 
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does that mean for revenue? (4) Where we are with potency of 
the drug. (5) What’s going on with people who are heavy users, 
meaning they use every single day or almost every single day. (6) 
Will cannabis legalization change use of other substances? (7) And 
then last, will legalization mean that more people come in to seek 
cannabis treatment or not? 
The most economic important thing to know about legalization is 
that it causes a price collapse. A word like decline or drop does not 
do it justice. It is a collapse. As fast as 2% per month (Humphreys, 
2017). Cannabis is easy to grow. Indeed, it can grow in a whole 
range of climates without any help from us, which is why we 
call it weed, right? Yet under Prohibition, it sells for the price of 
a precious metal. How could that possibly be the case? Well, as 
soon as you take away Prohibition, you see this extreme drop in 
price. Figure 3 displays Washington State data that I published in 
The Washington Post in 2017. It has gone down since. This is data 
per gram (Humphreys, 2017).
Figure 3




Figure 4 is wholesale prices in Colorado through January of 2017. 
Prices are down another third since the end of the time series 
data in the chart (Humphreys, 2017). And these are just going to 
continue to fall. So this is hugely important for multiple reasons.
Figure 4
Wholesale Price Per Pound of Marijuana in Colorado, 2014-2017
(Humphreys, 2017)
How low could it go? Much lower. The leading drug policy analyst 
Jonathan Caulkins (2019) points out that cannabis yields about one 
thousand pounds per acre. So you think, what does it cost, what 
is the production cost for an acre of typical agriculture? Well, if 
you look at tomatoes, it is about $10,000 per acre. If we use the 
calculation to convert that, then we can probably produce cannabis 
for a couple pennies per gram. Americans roll their joints at about 
.4 grams per joint, so that means a joint would be roughly two to 
three cents. Caulkins makes the analogy that it could be like the 
beer nuts they leave for you at the bar, something they do not even 
charge for (Caulkins, 2019). Or the chocolates they put on your 
pillow. And we’re down to actually $10 per gram or now $9 per 
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gram, so there’s still a long way, a long, long way to fall. It is possible 
that prices are going to fall again. They have already fallen 60%, 
70%, 80%, 90%. They could easily fall another 60%, 70%, 80%, 90%. 
Why Marijuana Prices Collapse
Why are marijuana prices collapsing? There are a couple of different 
reasons. We will start with a scenario about work. Let’s say you are 
a student at Syracuse University and you’re looking for a summer 
job. I run a furniture store in downtown Syracuse, and say, “Yeah, I 
want to hire you. All you have to do is stand in the showroom, and 
when people come in, you tell them about the furniture. If they 
like the furniture, you sell it to them. What do you think a fair wage 
is? $14 an hour?” And you say, “Yeah, okay, I’ll do it for $14 an 
hour.” But then I say, “Oh good, I should add a few more details. 
All the furniture is stolen and you could go to prison for selling 
it. And there’s another furniture store down the street, and that 
guy doesn’t like me, and he has a gun. So you might want to get a 
gun. And whatever you do, do not call the police.” Now how much 
money do you want to be paid? You are not going to do that for $14 
an hour, if you are even going to do it at all. You will get far fewer 
people who are willing to participate as labor in illegal markets, 
and you have to pay them to compensate them for the risk. Illegal 
markets also endure added costs because they have to operate 
secretly versus at scale. For example, standing on the street corner, 
selling crack, in Baltimore, you might only do, 10, 15, or 20 deals a 
day. However, a clerk in the supermarket can scan that many items 
in a few seconds, because they can be out in public. 
Also, if you’re a legal business, you have contract enforcement 
power from the government, i.e., if someone rips you off, you have 
access to the courts and the police. You don’t have any of that with 
an illegal business. You can’t walk into the police station and say, “I 
delivered this really top quality heroin and the guy didn’t pay me. 
I want him arrested.” Instead, you would say, “I’m going to get a 
Keith Humphreys
15
bunch of guys with guns together and we’re going to go try to get 
our money back.” That costs money and involves risk. Finally, legal 
businesses are also more successful because they have marketing 
expertise, which makes their product more appealing. They can 
hire the best minds of Madison Avenue to sell their wares; illegal 
organizations cannot. 
Implications for Taxes and Revenue
The decrease in the price of marijuana has big implications for how 
states design their taxation. A big reason many people voted for 
marijuana legalization is not because they cared about legalization 
per se, but because they thought they were going to get money 
through tax revenue. Imagine you have a product that’s falling in 
price really fast, and you pass a 20% tax and say, “This tax is going 
to bring in big bucks because cannabis costs $400 an ounce. We’re 
going to sell a million ounces a year. We take 20% of that and we’re 
going to build a bunch of highways and schools.” Then a year later, 
it’s $300 an ounce. That’s not as much, but we’ll still be okay. Now 
it’s $200 an ounce. Then it’s $100 an ounce. Then maybe it goes 
down to nothing. Then you are left saying, “Well, if somebody buys 
two joints, we put a penny tax on that and we’ll do something with 
that penny.” So your tax revenue chases prices down to the bottom. 
Ad valorem taxation brings in significant revenue only if the price 
doesn’t collapse. This happened in Colorado. They raised their 
percentage tax rate on cannabis and in 12 months, the decline in 
the price of cannabis market canceled out all the added revenue. 
The way to handle this is to tax in different ways. You can tax based 
on weight, e.g. $75 per ounce. Another way to do it is to say, “We 
don’t want marijuana to sell for a penny a joint. We are going to say 
the minimum price a legal merchant is allowed to charge is a dollar 
a joint,” or something along those lines, which both reduces use, 
but also then gives you more tax revenue. 
Lourie Lecture Policy Brief
16
Cannabis Potency
The downside of taxing cannabis by weight is potentially on the 
potency side. If I’m going to be charged per unit of weight, maybe 
I just try to grow 80% Tetrahydrocannabinol (THC) product all the 
time.You have to think about then also adding something that 
would discourage people from doing high potency, and there’s 
different ways to do that. Let me talk more about potency in general. 
Marijuana is a lot more potent than it used to be. According to data 
on the first 30 million sales in Washington State shown in Figure 5, 
the average THC potency of cannabis sold is about 20 % (Smart et 
al., 2017). THC is the principal intoxicant in the drug. Depending 
on how old you are, you may have a perception of cannabis that is 
different from what the current products are. If you used it in the 
70s or the 80s, you almost surely used a much lower potency drug. 
There are some products that go way higher than 20%, all the way 
to 60%, 70%, 80%, or 90%. We do not actually know what they do. 
However, there is some potential risk here. Just as you would be 
more worried if you caught your child with a bottle of vodka than a 
bottle of beer, you might more rationally worried about a product 
that is 20% versus 4% or 3%. 
Figure 5




Between 1995-2014, the average THC content has tripled, and 
Cannabidiol (CBD), which is another component of the plant, has 
halved. That is likely worrisome because it’s not definite, but it’s 
possible that CBD can temper some of the potential negative effects 
of THC. 
The Increase in Daily Marijuana Use
How people are using the drug is becoming a bit worrisome. More 
people are smoking cannabis now since legalization, but not a lot 
more. What’s driving the increase in the volume of consumption 
is really heavy use. So it’s not that there are vastly more people 
smoking cannabis once a week, it’s that there’s a lot more people 
who used to smoke it once a week who are now smoking it every 
day (Caulkins, 2019). This may be connected to falling prices and 
increasing potency. You can see Caulkins’ analysis of these data in 
Figure 6. 
Figure 6
Growth in Marijuana Use Reported in U.S. Household Survey
The green line represents how many people have used it in the last 
year, over a very long period. It’s gone up a little, as expected. It’s 
approximately twice as high as it was during it’s historical low point. 
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Most people wouldn’t be hugely concerned about that. On the 
other hand, people who use all day or nearly every day has gone 
up tenfold. Those users were a much smaller part of the cannabis-
using population in the past (Caulkins, 2019).
Figure 7 is from Jonathan Caulkins comparing people who drink 
every day versus people who use cannabis every day. The ratio 
between those two used to be 10 to 1, and now it’s almost even, 
as many people using cannabis every day tend to use alcohol every 
day. We know that for most drugs, if you use them a lot more, you 
at higher risk of enduring some kind of harm (Caulkins, 2019 ).
Figure 7
Frequent Cannabis Use Approaching Alcohol
If you go back 30 years, a typical cannabis user might have one 
joint on a weekend night; we’ll say 4% THC was the typical strength 
of a joint then. That works out to consuming an average of 4.6 
milligrams of THC a day. But if you have somebody who’s in the 
legal Washington market today and they’re a daily, near daily users, 
they’re consuming 300 milligrams of THC per day. That is more than 
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60 times as much. That is the same difference between chewing a 
coca leaf off the plant in Colombia and using cocaine, i.e., it is a big 
change. Additionally, that means much of what we know about the 
effects of cannabis is probably wrong because it’s based on these 
older, weaker cannabis which people didn’t use as much. So, if 
there’s more harm here, we would not necessarily know it yet. We 
will find out if people have problems in the future.
Increased Cannabis use and Effects on Alcohol and Opioid 
Related Harm
If there are increases in cannabis-related harm, maybe they will 
be traded off by reductions in problems with other substances. If 
cannabis legalization led to a doubling of cannabis use but alcohol 
use dropped by a quarter, we would likely be ahead because alcohol 
is so criminogenic. As a result, we would have less violence and 
we’d have fewer car accidents. People might say, “That’s a good 
trade. I’ll sign up for it.” Is that true? 
There are a few ecological studies showing that in geographic 
areas where medical cannabis has been legalized, the alcohol 
consumption is lower than expected and opioid overdoses are less 
prevalent than expected (Baggio et al., 2018). Theodore Caputi has 
written a smart critique noting how improbable the claims of these 
studies are (Caputi, 2019). For example, he notes a study claiming 
that medical cannabis reduced population alcohol consumption 
by 15%. Fifteen percent of U.S. alcohol consumption is almost 100 
million gallons of pure ethanol, which is 205 billion standard drinks. 
About 2.5% of Americans use medical cannabis, meaning that 
the study is concluding that 2.5% of Americans have collectively 
reduced their annual drinking by over 200 billion per year. The 
average user of medical cannabis would have to cut their alcohol 
consumption by 3,000 drinks a year for this to be true. For any one 
of them who did not drink to begin with, someone out there needs 
to cut their drinking by 6,000 drinks a year. Caputi’s critique is pretty 
Lourie Lecture Policy Brief
20
devastating for many of the studies claiming substitution effects 
of cannabis legalization. It is still theoretically possible that there 
could be substitution effects, but it’s hazardous to take aggregated 
correlational state-level studies at face value. 
The other hope is that cannabis use could reverse the opioid 
epidemic. This is a very common headline. Our group just tried to 
replicate these results using more data. Figure 8 is from our paper, 
led by Chelsea Shover, and published in the Proceedings of the 
National Academy of Sciences about a month ago (Shover et al., 
2019). The states that initially had medical cannabis had lower than 
expected rates of opioid overdose for a few years, as some studies 
reported. But when we followed it forward with much more data, 
the association switches to the other direction. We do not think 
that means medical cannabis is killing anybody now any more than 
it was saving anybody a few years ago. Rather, we think this is a 
textbook spurious association that has been over-hyped. 
Figure 8
Much-Touted Negative Correlation between Cannabis Access and 
Opioid Overdose Deaths has Reversed
(Shover et al., 2019)
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Since I’m in New York, I’ll go even further. It’s a terrible mistake 
of the New York Medical Board to say that people who are 
addicted to heroin and are taking an FDA-approved medication, 
like buprenorphine or methadone, can switch off medication and 
take medical cannabis (Humphreys & Saitz, 2019). That is extremely 
dangerous, and I think it is quite disappointing that New York State 
allows that. In my opinion, that is a shamefully low standard of 
proof of medical efficacy that we would not accept for any other 
population other than people who are addicted to drugs. 
Another point about correlational findings is that if you are going to 
believe some of them prove causality, you should have the integrity 
to believe that of all of them. If you are going to look at early studies 
that show medical cannabis correlates with fewer opioid overdoses, 
there are other correlational studies showing positive correlations. 
People who are in pain and use medical cannabis in addition to 
opioids use more opioids than those who do not (Degenhardt et 
al., 2015). In the national population, medical cannabis users have 
higher rates of prescription drug misuse than non-users (Caputi 
& Humphreys, 2018). Cannabis use predicts increased likelihood 
of developing prescription opioid use disorder over time (Olfson 
et al., 2018). These are all correlational studies. If we are going 
to deal with correlations, we have to accept the fact that they go 
in different directions. It is hard for an honest person to say we 
have proved this causal link when we have the correlations going 
in opposite directions in multiple studies. You have to cherry-pick 
pretty aggressively to come to that conclusion. 
Right now, we’ve got a lot of weak, overhyped science saying 
that cannabis legalization is going to solve the alcohol and opioid 
problem. There are a lot of corporate interests at play. Weedmaps 
(an online tool that assists in finding medical and recreational 
marijuana dispensaries, brands, etc.) took out billboards saying, 
“This will stop the opioid epidemic. It will save thousands of lives if 
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you legalize cannabis,” which incidentally would also make them a 
lot of money. I think it is important to protect the integrity of science 
in all this and just call them as we see them, and not steer towards 
a corporate or ideological interest, but just say what the facts are 
(Humphreys & Hall, 2019). Protecting the integrity of science and 
the public perception of scientific work might make us live or die as 
a species - I really believe that. Climate change is infinitely more of 
an important problem than cannabis. If we made cannabis one of 
the four food groups and mandated it’s use every day, it would still 
not be as bad as climate change. A big challenge we have in climate 
change is that some people do not believe scientists anymore, and 
ignoring science in the service of cannabis interests will only make 
that credibility problem worse. 
Cannabis Use Disorder Treatment
Will people still seek help for cannabis use disorder (CUD) 
treatment if the drug is legalized and normalized? Think of that 
young man and his mom from the story in the beginning of this 
paper. If marijuana is legalized and normalized, maybe people will 
think, “Well, cannabis can’t harm anyone, so any problem Richard 
is having couldn’t possibly be connected to all the cannabis he uses. 
He doesn’t need any treatment.” But what if Richard actually would 
benefit from cannabis treatment?
There is an argument that the only reason people ever go to seek 
cannabis treatment is because the police make them. An individual 
is arrested with cannabis in their car and the lawyer says, “If you 
enter treatment, the judge will like it, and you likely won’t get 
punished.” Then you go to treatment, but you don’t really buy it is 
needed. Is that the way we are going to be regarding cannabis use 




Daily/Near Daily Users are Reporting Lower Rates of CUD 
Symptoms
I find the data above in Figure 9 from Steve Davenport particularly 
interesting. Of this daily/near daily users group, they report lower 
rates of cannabis use disorder symptoms than they did in prior years 
(Davenport, 2018). When you ask heavy cannabis users whether 
they agree that “it’s interfering with my life, it’s causing social 
problems, causing work problems, I’m having trouble controlling it, 
I end up using more than I want to,” they are less likely to say yes 
to those questions today than they were in the past. Now there are 
multiple ways to explain this. Maybe it is true. Maybe once cannabis 
becomes legal, you do not endure those legal harms so it is, in fact, 
objectively less harmful. Or when it’s normalized, your spouse is 
less likely to criticize you for your heavy cannabis use. Therefore, it 
is less harmful. Maybe that is true. The other possibility is its just 
becoming normalized and people are not drawing connections 
that they objectively should. They are having problems because 
of their heavy cannabis use, but they think it cannot possibly be 
that because they have been convinced incorrectly that cannabis 
cannot cause problems. 
(Davenport, 2018)
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Figure 10
Court-Mandated Public Sector and Overall Marijuana Treatment 
Seeking (in 1000s)
Figure 10 shows treatment data from some work I did for the 
Washington Post . The blue area shows thousands of people who 
are forced into treatment by the legal system, and the orange are 
people who come to treatment otherwise (Humphreys, 2017). As 
you can see, the court-mandated public sector numbers are shrinking 
pretty fast. The court systems are directing fewer and fewer people 
into cannabis use disorder treatment. On the other hand, the rough 
amount of people seeking treatment overall stayed fairly flat. The 
only way that could be explained is fewer people are being forced 
in, but more people are choosing to come in. This is the opposite 
of what some people would have predicted under legalization, and 
suggests that more cannabis users are in fact experiencing harm 





U.K. also Showing Increase in CUD Treatment Seeking Despite 
Decreased Pressure
(Ashton, 2017)
Similar findings come from outside the United States. Figure 11 
contains British data on why people are coming into treatment. 
There is little legal pressure to seek cannabis use disorder treatment 
in the U.K. The chart above displays first-time treatment seekers 
on the right, and all treatment seekers on the left (Ashton, 2017). 
Cannabis is the number two reason for seeking help among all 
treatment seekers, and number one among first-time treatment 
seekers. They have very potent cannabis in the U.K., and these 
treatment data could be a sign that it’s harming users. On the 
European continent, the country that has the highest rate of 
voluntarily seeking treatment for cannabis use is the Netherlands; 
where there is zero pressure to seek treatment from the legal 
system (MacCoun, 2011).
Evidence to Consider for New York
Now I will discuss New York. These are some things one could 
consider if you decide to legalize cannabis. This comes from a paper 
that I worked on with my postdoctoral fellow, Chelsea Shover. It 
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will be out soon (Shover & Humphreys, Forthcoming). Let’s talk first 
about what an optimal regulatory structure would look like. You 
should not have a medical system unless it is, in fact, medical. The 
kind of faux systems we had in California, which allowed almost 
anyone to get it for anything, is bad for public health because 
people attribute medical knowledge and status to the industry, 
which it does not actually have. There is a recent study where a 
researcher had women pose as pregnant. They called dispensaries 
and 69% of them said, “You need to smoke cannabis during your 
pregnancy” (Dickson et al., 2018). That is not good medical advice. 
If a doctor did that and then the child had a problem, the doctor 
would be liable in some way. Unfortunately, the industry is not 
liable. People who did this in California, which was the first state to 
have medical cannabis, were very candid. They were doing this to 
legalize, not because they believed it was fundamentally medicinal. 
Now, the state has in fact legalized recreational cannabis, so I think 
we need to go back and say, “Why do we have this? Is it beneficial, 
is it harmful?” 
Some would say, “But there are health benefits to cannabis.” There 
are multiple therapeutic things that come out of the plant, and 
there will probably be more. However, there are plenty of healthful 
products that we do not sell through medical dispensaries. For 
example, if you have chronic urinary tract infections, you might 
drink cranberry juice because it makes your urine more acidic and 
that makes you less likely to get the infection. We do not have 
cranberry juice dispensaries. You buy it in the same stores as people 
who buy it because they like the taste of cranberry juice. It is not 
clear that there needs to be the separate system. It is better to put 
it all together and regulate it like a consumer product, and not give 
it the medical name, unless in fact it truly is medical. There are 
some states where it is medical, where you have to have multiple 
sclerosis or end stage cancer, and then you get it from doctor; that’s 
different. However, these faux medical things are bad. 
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State Monopolies or Regulating Licensing 
I would like people to think about state monopolies. I grew 
up with what was called an ABC store. There were still private 
companies that made all the beer, liquor, and wine that you have 
everywhere else, but you had to buy it at a store that was run by 
the government. There is a lot of literature on the impact. States 
that had ABC stores had lower rates of young people drinking 
and lower rates of vehicular death and drinking. Those stores did 
fewer promotions and they checked IDs more consistently (Cook, 
2007). The government also employed people of color at far higher 
rates than the private industry. The cannabis industry is very white 
(Posner, 2018). Therefore, there are a lot of gains, potentially, from 
doing that. We’d learn a lot if a state or two created state stores 
where people could legally buy cannabis.
If a state goes the fully commercial route, there are public health 
benefits to restricting the number of licenses. As with liquor stores, 
there is some point, both in terms of public health harm but also 
community amenity, where you can have too many sales outlets. 
This should be handled through licensing. Make the license hard 
to get. You can have some licensed outlets so people can buy what 
they want, but you also do not have 50 of them all in the same 
street in some neighborhood. 
Something commonly said is that we’re going to have really loose 
regulation at the beginning, but we’ll tighten it up over time. That’s 
the same as saying that once a U.S. corporation is really powerful 
and wealthy, regulating it becomes easier. That makes no sense and 
is exactly backwards. The chance to get in strong regulations are the 
greatest on the very first day. Ten years from now when you are on 
the other side of a table in Albany against a billion-dollar industry, 
your chance of tightening regulations up even modestly are pretty 
low. It makes much more sense to build strong regulations in at 
the outset, and then you can loosen up over time if you need to. 
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You should not count on being able to easily tighten up later; that 
hasn’t been the case with the pharmaceuticals, alcohol, tobacco, or 
any legal drug. 
For-Profit Model
If you have a for-profit industry, the public has an interest in 
determining how it is overseen rather than trusting it to never put 
profits over health. There are states where the industry oversight 
board has the industry on it. If you heard a state say, “We’re going 
to have a tobacco control agency that’s going to focus on reducing 
smoking among kids, and the people on the board are going to be 
our good friends from Philip Morris.” You would say, “Well, that’s 
crazy. That’s the fox guarding the henhouse.” There is still some of 
that going on with the design of some of these cannabis regulatory 
regimes. We need to start to think about the cannabis industry as 
a corporate, profit-seeking industry like any other. It is not run by 
gentle hippies wearing tie-dyes, putting a share of profits aside to 
save the whales. The people running the industry wear business suits 
and have law and business degrees. They are out to maximize profit 
and sales not public health or social justice. Some of the biggest 
investors in it are the tobacco and the alcohol industry. If you have 
it in your head that they are going to automatically do the right 
thing because they are altruistic, anti-materialistic activists, that is 
not accurate. They are going to be trying to make as much money 
as possible by generating as much heavy cannabis consumption as 
they can. Society has a strong interests in regulating them tightly as 
an industry. 
It is going to be important for integrity of science for us to have 
all the disclosure rules that we have around alcohol, tobacco, and 
pharmaceutical money, also apply to the cannabis industry. My 
journal, which I edit for the Americas, Addiction, does this. We 
treat it like any other industry. It does not mean cannabis industry 
funded people cannot produce research. However, you have to 
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disclose this so that readers know that the research was funded 
by the cannabis industry. The government can help reduce the 
potential problems of corporate funded research by funding its 
own research on the harms and benefits of cannabis use. 
Restraining Potency
What about different product regulation? I believe we should do 
something to restrain potency. I do not think there is a strong 
case to have a 50%, 60%, 70%, or 80% product, and I believe most 
people would be satisfied with lower-end products. Extremely 
strong products are implicated in many user panic attacks and 
emergency room visits. We can regulate cannabis product potency 
just as we have done with other products. You cannot make 150 
proof beer and call it beer. The laws of the state says beer is an 
alcoholic beverage that is in a certain range. We could do that with 
cannabis, setting a range for potency of different products.
We should also be honest about how little we know. We have many 
longitudinal studies of the impact of cannabis, but by definition, 
if I have a 20-year study on the effect of cannabis, it has to be 
old, weak strength, cannabis because it started 20 years ago. With 
most drugs, when you take them a lot more and at much higher 
potencies, they’re worse for you. Therefore, I have concerns about 
relying on studies of occasional users of weak cannabis. We have 
to be upfront when we give people health information, i.e., “Just 
remember, a lot of this is based on a much weaker product than 
you’re consuming right now.” 
We can also discourage high potency through tax policy. Alcohol is 
taxed more when it is stronger. As an alternative to a potency cap, 
policymakers could say that if someone wants to make a really 
strong product, they’re going to endure a tax bite on that product. 
The last idea, which some people are pushing, is if it turns out that 
this THC-CBD ratio proves to be important for health, we could tax 
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it on that basis. We could say, “If you make a really pure THC, no 
CBD, we’re going to tax that more than if they’re closer together 
because we think that’s less harmful.” We need to do some more 
science to find out if this is, in fact, true. 
Manufacturing Limits Could Protect Public Health
We could keep addictive products separate. I have said, “Please do 
not let them make tobacco-cannabis blended products,” to every 
state I’ve advised on this, and so far, virtually every state has done 
that. Think of the amount of trouble someone will go to make a 
blunt, which is basically carving out a cigar and then filling it with 
cannabis. If people are willing to do that, that tells you these are 
two great tastes that go great together. People are willing to work 
hard to get that combination of drugs. It is very common in Europe 
to blend them. If you were a company you would say, “Let’s make 
pre-blended packaged cannabis-tobacco cigarettes.” They may be 
very popular, but that would be bad for public health. It could bring 
back tobacco consumption. Reducing tobacco consumption is one 
of the great successes of public health in my lifetime. Therefore, 
we keep those things separate so they do not feed each other. 
Unfortunately, it is going to be difficult because it is roughly the 
same population. If you look at the economic, educational profile 
of the population that uses cannabis, it overlaps an awful lot with 
the population of people who smoke combusted cigarettes. 
We could also do things to restrict flavors in products. There are 
cannabis products that look like kids’ candies and they are full of 
THC. I do not see any need for us to allow those. Eliminating those 
products could reduce accidental poisonings. Adults will still be 
able to use cannabis, even if it’s not in the form of a gummy bear. 
There is a news story from The Canadian titled “Cronos CEO: $1.8 
Billion from Big Tobacco is just a Beginning for the Cannabis Industry” 
(Cherney, 2018). People say, “Will it be like the cannabis or alcohol 
industry?” Well, at least in Canada, cannabis is probably going to be 
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a division of those industries. $1.8 billion from Big Tobacco is just 
a beginning, and they are very well-poised to do this. They have 
the land, the technology, the rolling machines, they own the shelf 
space in all the stores, and they have the advertising expertise and 
the people on contract. It is very possible that this would be the 
future. The Big Tobacco would have a cannabis division. Maybe you 
are okay with that. If so, that is your right. However, my judgment 
of Big Tobacco is that it has been a health and regulatory disaster, 
so I view that possible future with dread. 
Prevent Price Collapse
Prices of cannabis will come down some, but there is no need to 
have one-cent joints. Some may say the opposite, but you have to 
remember that you are going to have a lot more use, specifically 
a lot more use among younger people. They are the most price 
sensitive. That is what we learned from taxing tobacco. There are 
different ways to do that. You could put taxes on cannabis, you can 
assign a minimum price, you can tax by weight, as I mentioned 
previously. Nevertheless, I think it is worth it to make sure that it is 
not as cheap as those free pretzels and nuts in the bar. 
Limit Marketing
There is a lot that can be done on marketing. U.S. law all the way up 
to the Supreme Court treats commercial speech like free speech, 
and whether one likes it or not, that is the way it is. However, you 
can still put in limits on marketing towards children. That is well 
established in law, but it is going to have to be done sophisticatedly. 
One of the problems is that the average person in Congress is 60 
years old, and often thinks protecting kids means TV shows cannot 
have cannabis ads until nine o’clock. What they often don’t realize 
is that young people don’t watch TV by the clock anymore, they 
watch it on their phones whenever they feel like watching it. We 
have to be more sophisticated about keeping cannabis ads away 
from young people because the incentive of the industry, of 
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course, is to get people to start using them young. Additionally, 
we might consider a plain packaging requirement, which is being 
done for tobacco in some places. That would take away many of 
the incentives for companies to build brands, so I believe it is worth 
considering. 
Public Consumption Policies
We have to make some decision about public consumption. There 
is more than one way to argue this. For example, secondhand 
smoke. People have legitimate reason not to want to be exposed to 
that, but it is far less than tobacco. The typical person who smokes 
cannabis smokes far fewer joints per day than a tobacco smoker 
smokes cigarettes a day. However, the secondhand smoke is there. 
We know that where kids congregate, having smoke-free zones 
is good in terms of reducing their likelihood of initiating tobacco. 
We could say that in those zones you would not be able to smoke 
cannabis. We may also want to designate locations, like cannabis 
clubs, where people can smoke, but separate them out from other 
substances. For example, you can buy the cannabis there but you 
could not buy alcohol. We might want to test that model to try to 
keep those habits from feeding each other. 
Prevent Impaired Driving
Driving impairment is a big issue that we really do not know what to 
do with at the moment. We do not know how to measure whether 
someone is impaired. THC is lipophilic, it sticks around the body 
much longer, and it’s much harder to assess whether someone is, 
in fact, intoxicated than it is with alcohol. Nonetheless, we should 
learn everything we can from the experience of drunk driving 
prevention and also put research dollars into developing a reliable 
field test for intoxication like we have for alcohol.
Keith Humphreys
33
Conclusion: Facilitate Rigorous Research
A lot more research is needed. We need to know a lot more about 
new cannabis. What these new products do has barely been 
studied. What happens when people use them every day versus 
occasionally? What happens when a teenager uses them every day 
when they are in their peak of brain development? What are the 
health effects of different modes of administration? That is another 
level of real complexity here. You can smoke it, you can vape it, 
you can eat it, and you can consume it as a wax or an oil. What 
are all those different effects? We really do not know. We need to 
study legalization more in the states. A lot of work has been done, 
but I think we need to look at different populations of people and 
how they are affected. Then, we need to examine the substitution 
question regarding other drug use. As I said, the research now 
does not support any conclusion. We need better research, such 
as knowing whether alcohol consumption changed as a result of 
marijuana usage. My hope is that it would go down, but I guess it 
would be very important to know if it goes up, too. I hope that is 
not the case. That’s a truly important thing to figure out, whether 
there’s a substitution effect, because there could be massive social 
welfare consequences one way or the other based on that particular 
phenomenon. 
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